Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Immunology | Infections and Infectious Diseases | Family Medicine
Disease Category: Staphylococcal Infections
Location: United States, NY
(MRSA) Methicillin-Resistant Staphylococcus Aureus
Winthrop University Hospital Clinical Trials Center in conjunction with The Winthrop Internal Medicine Association is conducting a clinical research study for patients who have been hospitalized for a skin and skin structure infection. This research study will look at effectiveness of two antibiotics.This study will compare the effectiveness of two FDA approved antibiotics used for the treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA).
During the study, eligible participants will receive study drug and all study procedures that are not part of the standard of care at no cost.
Compensation may be provided for time and travel.
Patient Inclusion Criteria:
To be eligible for the study, you must;
- Be at least 18 years of age
- Be hospitalized (for less than 24 hours)with a skin and skin structure infection of a complicated nature (major cutaneous absess or wound infection) that requires IV antibiotics treatment for 3 to 14 days of hospitalization management.
- Infection suspected or documented to be caused by MRSA
Winthrop University Hospital Clinical Trials Center
222 Station Plaza North
Mineola, NY 11501
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these